Professional overview
Dr. Kong Lin is a Chief Physician and Doctoral Supervisor at the Radiotherapy Center of Fudan University Shanghai Cancer Center, specializing in radiotherapy and comprehensive treatment for head and neck and central nervous system tumors.
Areas of focus
Background
- 1997Began clinical and research work in radiotherapy and comprehensive treatment for nasopharyngeal carcinoma and other head and neck and central nervous system tumors at the Department of Radiation Oncology, Fudan University Shanghai Cancer Center
- 2007Conducted two prospective clinical trials on induction chemotherapy with TPF regimen followed by conformal intensity-modulated radiotherapy plus concurrent chemotherapy for locally advanced nasopharyngeal carcinoma
- 2008Authored the chapter 'Second Primary Tumors' in the Encyclopedia of Cancer (Springer)
- 2012Conducted a phase III randomized controlled trial using nimotuzumab instead of cisplatin as a radiosensitizer during radiotherapy for locally advanced nasopharyngeal carcinoma
Experience & recognition
- Recipient of the Shanghai Anti-Cancer Association Science and Technology Award (Third Prize, 2019)
- Recipient of the Shanghai Anti-Cancer Association Science and Technology Award (Third Prize, 2020)
- Recipient of the Shanghai Anti-Cancer Association Science and Technology Award (First Prize, 2021)
- Recipient of the Michael Goitein Award from PTCOG (2023)
Professional roles
- Chair, Proton and Heavy Ion Radiotherapy Committee, China International Exchange and Promotive Association for Medical and Health Care (CPAM)
- Vice Chair, Particle Radiotherapy Committee, China Anti-Cancer Association (CACA)
- Standing Committee Member, Precision Oncology Committee, China Anti-Cancer Association (CACA)
- Standing Committee Member, Oral and Maxillofacial Tumor Integration Committee, China Anti-Cancer Association (CACA)
- Member, Nasopharyngeal Carcinoma Integration Committee, China Anti-Cancer Association (CACA)
- Standing Committee Member, Nasopharyngeal Carcinoma Prevention and Treatment Branch, China International Exchange and Promotive Association for Medical and Health Care (CPAM)
- Member, Glioma Committee, Chinese Medical Doctor Association (CMDA)
- Member, Neuro-Oncology Expert Committee, Chinese Society of Clinical Oncology (CSCO)
Frequently asked questions
What does Dr. Kong Lin specialize in?
Specializes in conventional photon intensity-modulated radiotherapy, proton and heavy ion radiotherapy, and comprehensive treatment for nasopharyngeal carcinoma, nasal cavity and paranasal sinus cancer, oral/oropharyngeal cancer, laryngeal cancer, hypopharyngeal cancer, salivary gland tumors, ocular tumors, meningioma, glioma, chordoma, adenoid cystic carcinoma, head and neck mucosal malignant melanoma, and olfactory neuroblastoma.
Which hospital and department is Dr. Kong Lin in?
At the Radiotherapy Center of Fudan University Shanghai Cancer Center
Sources
- Compiled from public information about the doctor's clinical title, department and areas of focus, rewritten by Find China Doctors.
- Medical licence: National Health Commission doctor registry
Dr. Kong Lin has not reviewed this page.
